R

Remedy Entertainment Oyj
OMXH:REMEDY

Watchlist Manager
Remedy Entertainment Oyj
OMXH:REMEDY
Watchlist
Price: 14.7 EUR -2% Market Closed
Market Cap: 200.5m EUR

Remedy Entertainment Oyj
Other Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Remedy Entertainment Oyj
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
R
Remedy Entertainment Oyj
OMXH:REMEDY
Other Operating Expenses
-€3.8m
CAGR 3-Years
-46%
CAGR 5-Years
5%
CAGR 10-Years
N/A
N
Nitro Games Oyj
STO:NITRO
Other Operating Expenses
-€1.6m
CAGR 3-Years
5%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Remedy Entertainment Oyj
Glance View

Market Cap
200.5m EUR
Industry
Media

Remedy Entertainment Plc engages in the production and development of story-driven console and computer games. The company is headquartered in Espoo, Etela-Suomen and currently employs 347 full-time employees. The company went IPO on 2017-05-29. The firm creates cinematic story-driven action console and computer games, which are published by partners, such as Microsoft, Rockstar Games and Smile Gate. The Company’s titles include Death Rally, Max Payne, Max Payne 2: The Fall of Max Payne, Alan Wake, Alan Wake's American Nightmare and Quantum Break, among others.

REMEDY Intrinsic Value
HIDDEN
Show

See Also

What is Remedy Entertainment Oyj's Other Operating Expenses?
Other Operating Expenses
-3.8m EUR

Based on the financial report for Dec 31, 2024, Remedy Entertainment Oyj's Other Operating Expenses amounts to -3.8m EUR.

What is Remedy Entertainment Oyj's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
5%

Over the last year, the Other Operating Expenses growth was 8%. The average annual Other Operating Expenses growth rates for Remedy Entertainment Oyj have been -46% over the past three years , 5% over the past five years .

Back to Top